drugset / Trial / NCT01016626
Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate safety and tolerance by comparing pharmacokinetic characteristics between the CKD-4101 tablet and Mycophenolate mofetil capsule when administered alone to healthy volunteers.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-08
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-4101 | Unknown | 1000 mg | Oral |
| Comparator | Mycophenolate Mofetil | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.